Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
Gini Health works in the domain of personalised healthcare
Subscribe To Our Newsletter & Stay Updated
